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Abstract 
We report the effect of the omithine transcarbamylase (OTC) transgene composed of 1.3 kb of the 5’ flanking region of the rat OTC 
gene fused to rat OTC cDNA on urinary erotic acid excretion in OTC-deficient spf-ash (sparse-fur with abnormal skin and hair) mice 
during overnight-starvation and nitrogen loading. During starvation, spf-ash mice with about 6% and 2% of control levels of OTC activity 
in the liver and small intestine excreted a large amount of erotic acid in the urine. Transgenic spf-ash mice with about 10% and 30% of 
the control OTC activities in the liver and small intestine did not excrete more than the normal level of erotic acid. Accidental 
parasitization of transgenic spf-ash mice with ticks (Myocoptes musculinus) resulted in decrease of the OTC activities in the liver and 
small intestine to the levels in spf-ash mice, and increased excretion of erotic acid. During extermination of the ticks, the mice showed 
varied levels of OTC activity and erotic acid excretion. On nitrogen loading, transgenic spf-ash mice as well as spf-ash mice excreted 
larger amounts of erotic acid, while control mice showed no increase in its excretion. The levels of urinary erotic acid were inversely 
correlated to the logarithms of the OTC activities in the liver and small intestine, the correlation being significantly higher with intestinal 
OTC than with hepatic OTC activity. These results suggest that the level of OTC activity in the small intestine is important for production 
of erotic acid. 
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1. Introduction 
Omithine transcarbamylase (OTC) is a mitochondrial 
enzyme located only in the liver and small intestine. 
Hepatic OTC is important in ammonia detoxication and 
bicarbonate excretion [l] as one of the urea cycle enzymes, 
whereas OTC in the small intestine is thought to supply 
citrnlline to the kidney for the synthesis of arginine [2]. It 
is not known whether intestinal OTC plays any role in 
ammonia detoxication. 
Two types of OTC-deficient mice have been described, 
Abbreviations: OTC, omithine transcarbamylase; Spf-ash, sparse-fur 
with abnormal skin and hair. 
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sparse-fur (spf) [3], and sparse-fur with abnormal skin and 
hair (spf-ash) [4], both having low OTC activity in the 
liver and small intestine [5,6]. Their molecular and genetic 
defects have been analyzed [7-91. As their names imply, 
they have delayed hair growth and, as in human OTC 
deficiency, they show hyperammonemia, erotic aciduria 
and low sernm concentrations of citrulline and arginine 
[3,4,10,111. 
Shimada et al. [12] introduced the rat OTC gene into 
OTC-deficient spf-ash mice by mating spf-ash hetero- 
zygotes with transgenic mice carrying recombinant DNA 
composed of 1.3 kb of the 5’ flanking region of the gene 
(containing the promoter region) fused to rat OTC cDNA 
[13]. The transgene caused increase in the OTC activity in 
transgenic spf-ash mouse liver from 5% to 12% of the 
control level and of that in the small intestine from 5% to 
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27%. Transgenic spf-ash mice showed normal hair growth 
without sparse-fur, and normalized urinary erotic acid and 
serum citrulline concentrations under fed conditions [ 121. 
Orotic aciduria is the most sensitive diagnostic criterion 
of OTC deficiency [14-161. In OTC deficiency, erotic acid 
is produced by leakage of accumulated carbamylphosphate 
in the mitochondria into the cytosolic pyrimidine nu- 
cleotide biosynthesis pathway [17-201. The only organs 
that could be responsible for erotic acid production are the 
liver and small intestine, where OTC is located. The liver 
is thought to be the major organ involved in erotic acid 
formation in OTC-deficient conditions. Isolated hepato- 
cytes, liver slices and perfused liver produce erotic acid in 
the presence of a high concentration of ammonia and 
especially when OTC activity is inhibited [l&20]. 
In the present study, we examined the relationship 
between urinary erotic acid and OTC activity in the liver 
and small intestine of control, heterozygous and spf-ash 
mice with and without the OTC transgene, and the effect 
of the introduced OTC transgene, especially during starva- 
tion and nitrogen loading. During the experiments, the 
mice were parasitized with mouse ticks, Myocoptes mus- 
culinus, and OTC expression of the transgene was sup- 
pressed. These mice provided additional data on the rela- 
tionship between OTC activity and urinary erotic acid and 
on the importance of the small intestine in production of 
erotic acid. 
Part of this work has been published as an abstract of 
the First IUBMB Conference on ‘Biochemistry of Disease’ 
held in Nagoya in 1992. 
2. Materials and methods 
2.1. Treatment of animals 
The mating programs were described by Shimada et al. 
[12]. Heterozygous spf-ash mice (X’/X), C57BL strain, 
were mated with transgenic mice (+ / - > of the same 
strain, descendants of No. 94, described by Murakami et 
al. [13]. 
We diagnosed the mice as spf-ash (X’/Y, - / - >, 
transgenic spf-ash (XI/Y, + / - >, heterozygotes (X’/X, 
- / - >, controls (X/X or X/Y, - / - >, and transgenic 
controls (X/Y, + / - ) by the polymerase chain reaction 
with modified primer as described by Kobayashi et al. 
[21]. Genomic DNA was isolated by the method of Mu- 
rakami et al. [13] or of Qi et al. [22]. 
The mice were separated from their mothers 28 days 
after birth and maintained on laboratory CE2 chow (24% 
protein) from Clea Japan. Mice 37 to 65 days old were 
used for experiments. After overnight starvation, they were 
housed individually in metabolic cages at 8:OO h, and urine 
specimens were collected for 4 h (starvation samples). At 
12:00 h, an aqueous solution of tryptone (5.6 g/kg body 
mass, or 46 mmol equivalent of amino acids/kg, Difco 
Laboratories, Detroit) was administered orally through a 
gastric tube (Clea Japan) connected to a l-ml syringe, and 
urine specimens were collected for a further 4 h (nitrogen 
load samples). During the experiments, water was avail- 
able ad libitum. Mice were killed for enzyme analysis at 
about 17:00 h. For assays of carbamylphosphate and amino 
acids in the liver or small intestine, mice were starved 
overnight and killed between 10:00 and 11:00 h by neck 
dislocation, and the liver or the upper part of the jejunum 
(about lo-15 cm length) was removed and freeze-clamped 
as quickly as possible in a solid CO,/acetone mixture. 
The study was carried out in accordance with the Guide 
Lines for Animal Experimentation of the Faculty of 
Medicine, Kagoshima University. 
2.2. Assay methods 
For assay of OTC activity, extracts of liver and small 
intestine were prepared by the method of Murakami et al. 
[13]. Activity was assayed by the method of Pierson et al. 
1231 with some modifications. To prevent inactivation of 
OTC by dilution and during incubation, the dilution buffer 
and assay medium contained 1 mg/ml and 2 mg/ml 
bovine serum albumin, respectively. One unit of enzyme 
activity defined as that forming 1 pmol of citrulline per 
min at 37°C. For Western blot analysis of OTC peptide, 
tissue extracts were subjected to sodium dodecylsulfate 
polyacrylamide gel electrophoresis by the method of 
Laemmli [24]. Protein bands were transferred to a nitro- 
cellulose filter, which was treated with rabbit antiserum 
against bovine OTC, and then with horse radish peroxi- 
dase-conjugated goat antibody to locate OTC peptide. For 
analysis of metabolites, freeze-clamped tissues were pul- 
verized in liquid nitrogen. The resultant powder was ho- 
mogenized with 4 vol. of 3% (w/v> sulfosalicylic acid for 
amino acid analysis. The extract was directly analyzed 
with a Hitachi 835 Amino Acid Analyzer (Hitachi, Japan). 
Extraction and assay of carbamylphosphate were per- 
formed by the method of Shigesada et al. [25]. Briefly, a 
perchloric acid extract of pulverized tissue was passed 
through a small column of Dowex 50-X8 (Hf-form, 200- 
400 mesh) in 1.5 M potassium bicarbonate solution with 
centrifugation at 150 X g for 1 min. The neutralized super- 
natant was incubated at 37°C for 30 min with [ l4 Clomithine 
and purified OTC at pH 8.2. The [‘4C]citrulline formed 
was separated from [14C]omithine by Dowex column chro- 
matography. An aliquot of the perchloric acid extract was 
heated at 95°C for 5 min and used as a sample blank. 
Urinary erotic acid and creatinine were measured by the 
methods of Kesner et al. [26] and Bonsnes and Taussky 
[27], respectively. 
2.3. Diagnosis and treatment of tick parasitization 
Tick parasitization was detected as tick worms and eggs 
by microscopic examination of hairs around the neck taken 
Table 1 
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OTC activities in the liver and small intestine of control, spf-ash and transgenic spf-ash mice, and urinary erotic acid during starvation and nitrogen loading 
Mice (n) OTC activity (U/mg protein) Urinary orotate (nmol/mg creatinine) 
liver small intestine starvation nitrogen load 
Control 
males (9) 1.6 + 0.14 0.25 f 0.027 300+70 210 f 80 
females (10) 1.7 f 0.09 0.26 + 0.033 180 + 100 160 + 70 
transgenic males (7) 1.6 + 0.12 0.26 f 0.046 330 + 190 210 + 90 
heterozygotes (9) 0.81 + 0.2 0.14 f 0.046 470 + 280 2200 + 1300 
spf-ash mice (6) 0.10 + 0.009 0.0057 + 0.0018 16600 + 12600 14200 k 2800 a 
transgenic spf-ash mice (8) 0.17 + 0.027 0.080 + 0.007 300 + 130 3100 + 1200 
Mice of 37 to 65 days old were used for experiments. After overnight starvation, they were housed individually in metabolic cages at 8:OO h. and urine 
specimens were collected for 4 h (starvation samples); at 12:OO h, an aqueous solution of tryptone (5.6 g/kg) was administered orally by gastric tube, and 
urine specimens were collected for a further 4 h (nitrogen load samples). Mice were killed at about 17:00 h, and the liver and small intestine were taken for 
determination of OTC activity. Values are mean f SD. for the numbers of mice shown in parentheses. a Mean f SD. for three animals. 
with sticky cellophane tape. For treatment, the parasitized 
mice were washed once a week for 5 weeks with a warm 
solution of 0.2% trichlorohydroxyethyl-dimethylphos- 
phonate (Bayer). No tick worms and eggs were detected 
after this treatment. 
3. Results 
3.1. OTC activities and urinary erotic acid excretion 
Table 1 summarizes the OTC activities in the liver and 
small intestine, and urinary erotic acid excretion during 
starvation and nitrogen loading. There was little difference 
in the OTC activities of male, female and transgenic male 
control mice. Heterozygous females showed about 50% of 
the control OTC activities with much greater variability in 
the standard deviation of the mean value, as expected for 
an X-linked enzyme. In the present experiment, spf-ash 
mice showed about 6% and 2% of the control OTC 
activities in the liver and small intestine, and transgenic 
spf-ash mice showed about 10% and 30%, roughly in 
agreement with previous data [12]. 
Heterozygous female mice excreted significantly higher 
concentrations of erotic acid than control females (P < 
0.05) during starvation, consistent with the results reported 
by Qureshi et al. [28,29]. The spf-ash mice excreted large 
amounts of erotic acid, but the transgenic spf-ash mice 
excreted erotic acid at the control level. 
Nitrogen was loaded to test the effect of the transgene 
under more stressed conditions. Under a nitrogen load of 
5.6 g tryptone/kg body mass, urinary erotic acid excretion 
increased in heterozygotes, spf-ash, and transgenic spf-ash 
mice. Transgenic spf-ash mice excreted much less erotic 
acid than spf-ash mice (P < 0.05). No increase was ob- 
served in control mice. These results indicate that the 
increase of OTC activities in the transgenic spf-ash mice 
due to the introduction of the transgene used in the present 
experiment is effective but not sufficient to normalize 
urinary erotic acid under certain stressed conditions. 
3.2. Effect of tick parasitization on OTC activities and 
urinary erotic acid excretion 
During the experiments, almost all the mice were found 
to be parasitized with mouse ticks (Myocoptes musculinus). 
Scarcely any spf-ash mice survived and the transgene was 
not effective for survival (data not shown). Surprisingly, 
the OTC activities in the liver and small intestine of the 
transgenic spf-ash mice were reduced to the levels of the 
Table 2 
OTC activities in the liver and small intestine, and urinary erotic acid of transgenic spf-ash mice during tick parasitization 
Mice OTC activity (U/mg protein) Urinary orotate (nmol/mg creatinine) 
liver small intestine starvation nitrogen load 
atthepeak(n=6) 0.095 + 0.015 0.0032 + 0.0025 3060 f 2060 11800 k 3500 
during extermination 
No. 333 0.128 0.080 390 4690 
334 0.068 0.088 1030 8160 
413 0.138 0.028 3850 5040 
468 0.117 0.064 340 4180 
475 0.238 0.0087 5640 10600 
479 0.117 0.066 360 4192 
Experimental procedures are described in Table 1. Data on mice at the peak of tick parasitization are shown as mean f S.D. and typical individual data are 
shown for mice during extermination of ticks. 
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Fig. 1. Western blot analysis of OTC in the liver of control, spf-ash and 
transgenic spf-ash mice with and without tick parasitization. Liver ex- 
tracts were prepared by homogenization of liver specimens with 9 vol. of 
50 mM Hepes-potassium buffer (pH 7.5), containing 1% Triton X-100 
and 20% glycerol and centrifugation at 15000 X g for 10 min. The 
extracts were heated at 95°C for 5 min with sodium dodecylsulfate and 
pmercaptoethanol, and subjected to sodium dodecylsulfate-polyacryl- 
amide (10%) gel electrophoresis and immunoblot analysis as described in 
Section 2. Samples of 3 mg of liver extract were applied to each lane. 
Sources of samples; lanes 1 and 2, transgenic spf-ash mice without tick 
parasitization (OTC activity, 0.20 and 0.19 U/mg protein, respectively); 
lane 3, transgenic spf-ash mice with tick parasitization (0.048 U/mg); 
lane 4, spf-ash mice (0.10 U/mg); lane 5, control mice (1.87 U/mg). 
spf-ash mice (Table 2). The reduction of OTC activity was 
accompanied by a reduction in OTC protein detected by 
Western blot analysis, as shown in Fig. 1. The densities of 
OTC protein bands detected in the liver of control, spf-ash 
and transgenic spf-ash mice were parallel with the OTC 
activities. Similar results were obtained with samples from 
the small intestine of the animals (not shown). There was 
no detectable change in OTC activity in control mice 
during tick parasitization and we did not obtain informa- 
tion about spf-ash mice except their very low survival rate. 
Consistent with the decrease in OTC activities, the urinary 
erotic acid of tick-parasitized transgenic spf-ash mice in- 
creased markedly during starvation and increased even 
further to the level of spf-ash mice on nitrogen loading. 
During extermination of the ticks, both the OTC activities 
and urinary erotic acid excretion gradually returned to the 
levels of transgenic spf-ash mice without tick parasitiza- 
tion. As shown in Table 2, the decrease in urinary erotic 
acid during starvation was parallel with increase in OTC 
activity in the small intestine. In mice Nos. 333, 468 and 
479, the urinary erotic acid level was normal in spite of 
low hepatic OTC activity. On the other hand, the increase 
in hepatic OTC to 8.7 and 15% of the control level with a 
little or no increase in mice intestinal OTC in No. 413 and 
475 caused no reduction in urinary erotic acid. These 
results suggest that urinary erotic acid excretion is normal- 
ized by increase in intestinal OTC activity. 
3.3. Relationship between OTC activity and urinary erotic 
acid excretion during starvation and nitrogen loading 
To determine the relationship between OTC activity and 
urinary erotic acid excretion, we plotted individual data in 
starvation and nitrogen loading, as shown in Figs. 2 and 3. 
Values on the abscissa for OTC activities are shown on a 
logarithmic scale because this plot gave a good correlation 
between the parameters in the nitrogen-loaded condition, 
as shown in Fig. 3. The four panels show the roles of 
hepatic and intestinal OTC activities in erotic acid produc- 
tion and the effect of the transgene in spf-ash mice and of 
tick parasitization. The level of urinary erotic acid in 
control mice during starvation was found to be less than 
600 nmol/mg creatinine, as shown in Fig. 2. Three of 9 
heterozygous female mice excreted a slightly higher con- 
centration of erotic acid, although their OTC activities 
were higher than those of the transgenic spf-ash mice, 
none of which excreted over the normal level under condi- 
tions without tick parasitization. This was probably be- 
cause a portion of the hepatocytes or small intestinal cells 
I 
Liver 
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??
0 
Liver 
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Small Intestine 
OTC Activity (U/mg) 
Fig. 2. Relationship between OTC activity in the liver (left panels) and 
small intestine (right panels) and urinary erotic acid of control, heterozy- 
gous and spf-ash mice with and without the OTC transgene during 
starvation. Experimental procedures are described in Table 1. The upper 
panels show data for control males with and without the transgene (0 ), 
female controls (01, and heterozygous (shaded circles) and spf-ash (m) 
mice. The lower panels show data for transgenic spf-ash mice with (0 ) 
and without (0, shaded) tick parasitization. OTC activity is shown on a 
logarithmic scale. The upper range of control values for urinary erotic 
acid (600 nmol/mg cr) is shown by a dashed line. Cr denotes creatinine. 
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Fig. 3. Relationship between OTC activities in the liver (left panels) and 
small intestine (right panels) and urinary erotic acid on nitrogen loading. 
Experimental procedures were as described in Table 1. Data shown in 
upper panels are from control, heterozygotes and spf-ash mice and in 
lower panels from transgenic spf-ash mice. Symbols used are as in Fig. 2. 
Regression equations between OTC activities and urinary erotic acid 
concentrations shown as dotted lines were calculated from all the data in 
upper and lower panels and expressed by the following formulae: for 
hepatic OTC, [Orotate(nmol/mg cr.)] = 1480-6770 X log[OTC 
act.(U/mg)]; for intestinal OTC, [Orotate(nmol/mg cr.)] = - 3030-6000 
Xlog[OTC act.(U/mg)]. The correlation coefficients with the hepatic and 
intestinal OTC activities were calculated to be r = -0.786 and r = 
- 0.901, respectively. 
of the heterozygotes contained less OTC than those of 
transgenic spf-ash mice owing to the lyonization of the 
X-chromosome. 
The right panel of Fig. 2 shows the relationship be- 
tween intestinal OTC activity and urinary erotic acid: the 
level of erotic acid was higher than normal in animals with 
OTC activity of below 0.03 U/mg, and normal or nearly 
normal in those with activity of above 0.06 U/mg. In 
contrast, there is no clear relationship between the hepatic 
OTC activity and urinary erotic acid in transgenic spf-ash 
mice, as illustrated in the lower left panel: three cases with 
OTC activity of below 0.13 U/mg showed normal erotic 
acid excretion and one with OTC activity of more than 
0.17 U/mg showed very high erotic acid excretion. These 
results again suggest that the level of urinary erotic acid 
excretion in transgenic spf-ash mice depends on the intesti- 
nal OTC activity. There was no clear statistical relation- 
ship between OTC activity and urinary erotic acid during 
starvation (Fig. 2), probably because the amount of nitro- 
gen substrate for carbamylphosphate synthesis was subsat- 
urated and varied in different mice. 
We also performed a nitrogen loading test to clarify the 
relationship between OTC activity and urinary erotic acid 
and the role of intestinal OTC activity in the production of 
erotic acid. We calculated correlation coefficients and 
regression equations using data from control, heterogy- 
zous, spf-ash and transgenic spf-ash mice with and without 
tick infection. In Fig. 3, dotted lines indicate regression 
lines. The results show that urinary erotic acid excretion 
was inversely correlated with the logarithm of OTC activ- 
ity. A significantly higher correlation coefficient between 
urinary erotic acid concentrations and OTC activities was 
obtained for intestinal OTC (r = - 0.901) than for hepatic 
OTC (r = -0.786) (P < 0.05, n = 56). The plots in the 
lower left panel of Fig. 3 showing the relationship between 
hepatic OTC and urinary erotic acid seem to be divided 
into a high erotic acid group (12700 + 1340 nmol/mg 
creatinine; n = 6) above the dotted line and a low erotic 
acid group (4050 + 1690 nmol/mg creatinine; n = 13) 
below the line, even though there was no difference in the 
hepatic OTC activities in these two groups (0.119 +_ 0.060 
U/mg versus 0.142 f 0.040 U/mg). The high and low 
erotic acid groups, however, roughly corresponded to 
groups with low and high intestinal OTC activity (0.0044 
+ 0.0003 U/mg and 0.068 f 0.026 U/mg; P < O.OOl), 
as shown in the lower right panel of Fig. 3. 
3.4. Concentrations of carbamylphosphate in the liver and 
small intestine 
We measured the concentrations of carbamylphosphate 
in the liver and small intestine during starvation to exam- 
ine the effect of reduced OTC activity on erotic acid 
production (Table 3). The control levels of carbamylphos- 
phate in the present study were compatible with published 
data [25,30,31]. The concentration in the small intestine of 
spf-ash mice was about 3 times that of control mice 
(P < 0.01) and was decreased to the control level by 
introduction of the OTC transgene. On the other hand, that 
in the liver of spf-ash mice varied (range: 0.73-23.8 
nmol/g liver for spf vs. 0.79-2.1 nmol/g for control 
mice), although the mean was not significantly different 
from that of the controls. All these results strongly suggest 
that the small intestine plays an important role in the 
production of erotic acid in OTC deficiency. 
Table 3 
Concentration of carbamylphosphate in the liver and small intestine of 
control, spf-ash and transgenic spf-ash mice on overnight-starvation 
Mice Liver Small intestine 
(nmol/g tissue) (nmol/g tissue) 
control 1.3kO.6 (6) 0.24+0.10 (3) 
spf-ash 4.8Ifr6.8 (11) 0.78 + 0.33 (8) 
transgenic spf-ash 1.0*0.5 (3) 0.19 f 0.04 (3) 
Carbamylphosphate was extracted and assayed as described in Section 2. 
Numbers in parentheses indicate numbers of determinations. 
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4. Discussion 
As we reported previously [12], spf-ash mice with the 
OTC transgene show normal hair growth without sparse 
fur, normalized urinary erotic acid excretion and normal- 
ized serum citrulline concentration in fed conditions. Simi- 
lar results have been reported in OTC-deficient mice (spf 
or spf-ash) carrying an SV40 promoter-human OTC cDNA 
transgene [32] or a mouse OTC promoter-human OTC 
cDNA transgene [33]. However, the effects of OTC trans- 
genes under stress conditions have not been studied. 
In our present study, the mice were submitted to two 
stress conditions, starvation and nitrogen loading, to assess 
the therapeutic effect of the OTC transgene. The transgenic 
spf-ash mice showed normal urinary erotic acid excretion 
during starvation, values rather being lower than those of 
heterozygotes (Table 1 and Fig. 21, suggesting the high 
therapeutic efficacy of the transgene. However, during 
nitrogen loading, urinary erotic acid excretion increase 
inversely with OTC activity in the liver and small intestine 
(Fig. 3). Thus, the OTC activity in transgenic spf-ash mice 
was insufficient under certain stress conditions. In addi- 
tion, almost all heterozygotes tested showed higher levels 
of urinary erotic acid than control mice, confirming the 
diagnostic value of a nitrogen load test for carrier detec- 
tion. 
As we described previously [12], the transgene produces 
no increase in OTC activity in control mice in contrast to 
the considerable increase in transgenic spf-ash mice. The 
reason for this is not known. 
Accidental tick parasitization caused a reduction in the 
OTC activity of the transgenic spf-ash mice, which was 
accompanied by a reduction in the amount of OTC protein 
(Fig. 1). Preliminary studies on OTC mRNA suggested 
that the suppression was caused by suppression of gene 
expression of the transgene. Further study is needed to 
clarify the precise mechanism, which may be important for 
clinical application of gene therapy. Anyway, the increase 
in urinary erotic acid excretion occurred coincidentally 
with reduction in OTC activities in both conditions tested. 
The most remarkable finding, obtained during extermina- 
tion of the ticks, was that urinary erotic acid excretion in 
transgenic spf-ash mice during starvation was normalized 
by increase in intestinal OTC activity without any increase 
in hepatic OTC activity. 
Our supposition that the small intestine is involved in 
the production of erotic acid in OTC deficiency is sup- 
ported by the higher level of carbamylphosphate in the 
small intestine of spf-ash mice than in control. It is surpris- 
ing that the small intestine should be involved in erotic 
acid production in OTC-deficient conditions, because erotic 
aciduria is frequently observed in argininosuccinate syn- 
thetase and arginase deficiencies [15], in which the liver, 
not the small intestine, is involved. Orotic acid production 
has been demonstrated experimentally by using systems 
such as liver slices, hepatocytes and perfused liver [18-201, 
but the role of the small intestine in erotic aciduria in OTC 
deficiency has not hitherto been examined. The small 
intestine plays a role in arginine supply [2] via production 
and release of citrulline. Windmueller and Spaeth calcu- 
lated the rate of intestinal citrulline production in rats to be 
about 6.5 pmol per h per 100 g body mass [2]. In the case 
of complete deficiency of intestinal OTC, we posit the 
value as the rate of erotic acid production in the small 
intestine, if there is no rate-limiting step from mitochon- 
drial carbamylphosphate to erotic acid. The small intestine 
exhibits frequent mitotic division and its enzyme activities 
for pyrimidine nucleotide biosynthesis are as high as or 
higher than those in the liver [34,35]. In our experiments, 
the maximal rate of erotic acid production in spf-ash mice 
was calculated to be about 3 pmol per h per 100 g body 
mass, which is compatible to the above value. These 
considerations again suggest that the small intestine may 
produce erotic acid. We tried to obtain direct evidence for 
the production of erotic acid in OTC-deficient small intes- 
tine by estimating the difference in erotic acid concentra- 
tions in the portal vein and arteria in comparison with that 
in the hepatic vein and portal vein, but both differences 
were too small to verify the production of erotic acid in 
the small intestine or liver (data not shown). 
Alternatively, erotic acid production in the liver of 
OTC-deficient mice may be enhanced by OTC deficiency 
in the small intestine. The most important factors in the 
production of erotic acid via the mitochondrial car- 
bamylphosphate synthetase pathway are thought to be an 
increased supply of ammonia and a limited OTC reaction 
caused by OTC deficiency, inhibition of OTC and/or a 
limited supply of omithine. A low intestinal OTC activity 
causes arginine deficiency, as observed in cases of OTC 
deficiency and hyperammonemia caused by massive resec- 
tion of the small intestine [36,37]. This may result in a 
reduced supply of arginine to the liver, or a reduced supply 
of citrulline from the small intestine directly to the liver. In 
either, this would subsequently result in a low supply of 
ornithine, which is essential for the OTC reaction. We 
found that the omithine concentration in the liver of 
spf-ash mice was significantly lower than that in controls 
(245 f 81 nmol/g (n = 9) vs. 338 * 155 nmol/g (n = 7); 
P < 0.05). Conceivably this difference in ornithine concen- 
trations affects the flux through OTC, because the values 
are compatible with those under arginine-deprived and 
control conditions, respectively, in the experiments by 
Alonso and Rubio [31] on erotic aciduria due to arginine 
deprivation. The supply of ammonia may also be increased 
by increased catabolism caused by a limited supply of 
arginine. Tick parasitization also probably results in in- 
creased catabolism. The concentration of carbamylphos- 
phate in the liver of spf-ash mice was variable and in some 
case was more than 10 times that of controls, indicating 
that liver produces erotic acid under as yet unidentified 
conditions. 
A much higher correlation was obtained between OTC 
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activities and urinary erotic acid during starvation than 
during nitrogen loading. This was probably because when 
the same amounts of nitrogen and arginine (about one 
twentieth of the total amount of amino acids administered) 
were supplied to the mice, the limiting factor was OTC 
activity. We have no explanation why erotic acid excretion 
is inversely proportional to the logarithm of OTC activity, 
not directly to the activity. This fact, however, indicates 
that the decrease in OTC activity has an accerelating effect 
on erotic acid production. Decrease in OTC activity may 
exert multiple effects on nitrogen metabolism. Even under 
these conditions, intestinal OTC activity was shown to be 
more closely correlated than hepatic OTC activity to uri- 
nary erotic acid (Fig. 3). 
The present results are important in considering gene 
therapy for OTC deficiency because they indicate that 
somatic introduction of OTC gene into small intestinal 
cells may be therapeutically effective. Jones et al. [33] also 
suggested that intestine-targeted gene transfer should be 
effective for OTC deficiency because their transgenic spf- 
ash mice with high levels of OTC activity in the small 
intestine but little or none in the liver showed phenotypical 
and biochemical correction of OTC deficiency. Their value 
for OTC activity may not, however, be reliable: the OTC 
activity of their control mice was much lower than that in 
many other reported studies and that in the small intestine 
of control mice was about half that of OTC-deficient 
spf-ash mice, which is not consistent with data of others 
[5,6] including those in our previous [12] and present 
study. Further analyses are required on the possible role of 
intestinal OTC in ammonia metabolism in general and in 
erotic acid production in OTC deficiency. 
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